GB1229888A - - Google Patents

Info

Publication number
GB1229888A
GB1229888A GB1229888DA GB1229888A GB 1229888 A GB1229888 A GB 1229888A GB 1229888D A GB1229888D A GB 1229888DA GB 1229888 A GB1229888 A GB 1229888A
Authority
GB
United Kingdom
Prior art keywords
informationally
viruses
antigen
influenza
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1229888A publication Critical patent/GB1229888A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1229888D 1967-06-19 1968-06-19 Expired GB1229888A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEJ0033936 1967-06-19

Publications (1)

Publication Number Publication Date
GB1229888A true GB1229888A (nl) 1971-04-28

Family

ID=7204943

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1229888D Expired GB1229888A (nl) 1967-06-19 1968-06-19

Country Status (13)

Country Link
AT (1) AT282821B (nl)
BE (1) BE716806A (nl)
BR (1) BR6899970D0 (nl)
CH (1) CH513241A (nl)
DE (1) DE1617545C2 (nl)
DK (1) DK119724B (nl)
ES (1) ES355121A1 (nl)
FR (2) FR1588820A (nl)
GB (1) GB1229888A (nl)
IE (1) IE32140B1 (nl)
IL (1) IL30168A (nl)
NL (1) NL6808486A (nl)
NO (1) NO124840B (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224404A (en) 1976-12-16 1980-09-23 The International Institute Of Differentiation Limited Production of specific immune nucleic acids cell dialysates and antibodies
GB2216416A (en) * 1988-03-11 1989-10-11 Sandoz Ltd Immunostimulating compositions comprising nucleobase sources

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754934A (fr) * 1969-08-16 1971-02-17 Jachertz Diether Procede de production enzymatique d'arn-messager
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224404A (en) 1976-12-16 1980-09-23 The International Institute Of Differentiation Limited Production of specific immune nucleic acids cell dialysates and antibodies
GB2216416A (en) * 1988-03-11 1989-10-11 Sandoz Ltd Immunostimulating compositions comprising nucleobase sources
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system

Also Published As

Publication number Publication date
BE716806A (nl) 1968-12-19
FR7781M (nl) 1970-03-23
DK119724B (da) 1971-02-15
NO124840B (nl) 1972-06-12
BR6899970D0 (pt) 1973-02-13
AT282821B (de) 1970-07-10
CH513241A (de) 1971-09-30
FR1588820A (nl) 1970-03-16
NL6808486A (nl) 1968-12-20
IE32140L (en) 1968-12-19
ES355121A1 (es) 1969-11-16
IE32140B1 (en) 1973-04-18
IL30168A (en) 1973-05-31
DE1617545C2 (de) 1983-11-03
DE1617545A1 (de) 1971-04-01
IL30168A0 (en) 1968-08-22

Similar Documents

Publication Publication Date Title
Wiktor et al. Cultivation of rabies virus in human diploid cell strain WI-38
Barnard Rift Valley fever vaccine-antibody and immune response in cattle to a live and an inactivated vaccine
Oxford et al. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection
Wiktor et al. Human cell culture rabies vaccine: antibody response in man
Webster et al. Potentiation of the immune response to influenza virus subunit vaccines
Zygraich et al. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus
CA1045546A (en) Highly attenuated cytomegalovirus vaccine and production thereof
Atanasiu et al. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3
GB1229888A (nl)
Nicholson et al. Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon
US3927208A (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
Fekadu et al. An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge
Zinkernagel Antiviral T-cell memory?
Glasgow et al. Isoprinosine: lack of antiviral activity in experimental model infections
JPH05501401A (ja) 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法
US3629413A (en) Polyvalent bovine vaccines and methods of making and using same
Norrby et al. Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus
Laver et al. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine
Millian et al. Antibody response of man to canine distemper virus
US5006335A (en) Live vaccine against mumps and process for obtaining thereof
McNeill The antibody response of rabbits to inactivated vaccinia virus
McLaren et al. Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization
Luzzio Demonstration of blood group substance A bound to Pasteurella pestis
Srivastava et al. Studies on the immunogenicity of Streptococcus equi vaccines in foals.
Norrby Characteristics of the progeny derived from multiplication of Sendai virus in a measles virus carrier cell line

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee